Selection from HEOR Bibliography

IMS logo
Search criteria
Country: Japan
 
Empagliflozin is Associated with Lower Risk of Cardiovascular Events and All-Cause Mortality in Routine Care in East Asia: Results from the EMPRISE Study
Authors: Dae Jung Kim (1), Wayne H-H Sheu (2), Wook-Jin Chung (3), Daisuke Yabe (4-7), Kyoung Hwa Ha (1), Masaomi Nangaku (8), Elise Chia-Hui Tan (9), Koichi Node (10), Atsutaka Yasui (11), Weiyu Lei (12), Sunwoo Lee (13), Laura Saarelainen (14), Anouk Deruaz-Luyet (15), Moe H. Kyaw (16) and Yutaka Seino (4,17), EMPRISE East Asia Study Group
Affiliations: "1 Department of Endocrinology and Metabolism, Ajou University School of Medicine, Suwon, South Korea 2 Division of Endocrinology and Metabolism, Taipei Veterans General Hospital, Taipei, Taiwan 3 Department of Cardiovascular Medicine, Gachon University Gil Medical Center, Incheon, South Korea 4 Kansai Electric Power Medical Research Institute, Kobe, Japan 5 Department of Diabetes, Metabolism and Endocrinology/Department of Rheumatology and Clinical Immunology, Gifu University Graduate School of Medicine, Gifu, Japan 6 Center for Healthcare Information Technology, Tokai National Higher Education and Research System, Nagoya, Japan 7 Division of Metabolism and Molecular Medicine, Kobe University Graduate School of Medicine, Kobe, Japan 8 Division of Nephrology and Endocrinology, The University of Tokyo, Tokyo, Japan 9 National Research Institute of Chinese Medicine, Ministry of Health and Welfare, Taipei, Taiwan, and Institute of Hospital and Healthcare Administration, National Yang-Ming University, Taipei, Taiwan 10 Department of Cardiovascular Medicine, Saga University, Saga, Japan 11 Nippon Boehringer Ingelheim Co. Ltd., Tokyo, Japan 12 Boehringer Ingelheim Taiwan Ltd., Taipei, Taiwan 13 Boehringer Ingelheim Korea Ltd, Seoul, Korea 14 IQVIA, Espoo, Finland 15 Boehringer Ingelheim International GmbH, Ingelheim, Germany 16 Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, USA 17 Kansai Electric Power Hospital, Osaka, Japan "
Publications: 
"JDI journal Virtual Conference: ACC, May 2021"
Document Types: , Article
Countries: , Japan, Korea, Taiwan
Abstract: https://doi.org/10.1111/jdi.13959
Condition Year Language Analysis type
, Cardiovascular disease, Diabetes, Drug safety, Drug Utlization Study 2023 English , Clinical setting: hospital, Clinical setting: Primary care, Retrospective cohort analysis
 
 
Cost-effectiveness analysis of ranibizumab biosimilar for neovascular age-related macular degeneration in Japan
Authors: Yasuo Yanagi 1, Kanji Takahashi 2, Tomohiro Iida 3, Fumi Gomi 4, Junko Morii 5, Eriko Kunikane 6, Taiji Sakamoto 7 (rwesheorj 5)
Affiliations: 1) Department of Ophthalmology and Microtechnology, Yokohama City University, Kanagawa, Japan 2) Department of Ophthalmology, Kansai Medical University, Osaka, Japan 3) Department of Ophthalmology, Tokyo Women's Medical University School of Medicine, Tokyo, Japan 4) Department of Ophthalmology, Hyogo Medical University, Hyogo, Japan 5) IQVIA Solutions Japan, K.K., Tokyo, Japan 6) Senju Pharmaceutical Co., Ltd., Osaka, Japan 7) Department of Ophthalmology, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan
Publications: 
Ophthalmology and Therapy
Document Types: , Article
Countries: , Japan
Abstract: https://link.springer.com/article/10.1007/s40123-023-00715-y
Condition Year Language Analysis type
, Vascular disease 2023 English , Cost analysis, Cost effectiveness
 
 
Assessing definitions and incentives adopted for innovation for pharmaceutical products in five high-income countries: a systematic literature review
Authors: Naohiko Wakutsu 1, Emi Hirose 2, Naohiro Yonemoto 3, Sven Demiya 4 (rwesheorj 4)
Affiliations: 1) Graduate School of Economics, Nagoya City University, Nagoya, Japan 2) Health & Value, Pfizer Japan Inc., Tokyo, Japan. emi.hirose@pfizer.com 3) Health & Value, Pfizer Japan Inc., Tokyo, Japan 4) IQVIA Solutions Japan K.K., Tokyo, Japan
Publications: 
Pharmaceutical Medicine
Document Types: , Article
Countries: , France, Germany, Japan, UK, USA
Abstract: https://link.springer.com/article/10.1007/s40290-022-00457-5
Condition Year Language Analysis type
, Miscellaneous 2023 English , Literature Review
 
 
Patient burden associated with treatment-resistant or unexplained chronic cough - a qualitative study based on focus group interviews
Authors: Naoya Ueda 1, Anzu Yakushiji 2, Shigeru Tokita 1, Takekazu Kubo 1 (rwesheorj 2)
Affiliations: 1) MSD Co., Ltd., Medical Affairs 2) IQVIA Solutions Japan K.K., Tokyo, Japan
Publications: 
Progress in Medicine
Document Types: , Article
Countries: , Japan
Abstract: https://mp.medicalonline.jp/products/detail.php?content_kind=0&content_detail_key=ai5prmda%2F2023%2F004302%2F014%2F0167-0181
Condition Year Language Analysis type
, Respiratory disease 2023 Japanese , Burden of illness, Patient questionnaire
 
 
Identification and management of connective tissue disease-associated interstitial lung disease: evidence-based Japanese consensus statements
Authors: Masataka Kuwana 1, Masashi Bando 2, Yutaka Kawahito 3, Shinji Sato 4, Takafumi Suda 5, Yasuhiro Kondoh 6; CTD-ILD Delphi Collaborators (rwesheorj A)
Affiliations: 1) Department of Allergy and Rheumatology, Nippon Medical School Graduate School of Medicine, Tokyo, Japan. 2) Division of Pulmonary Medicine, Department of Medicine, Jichi Medical University, Tochigi, Japan. 3) Inflammation and Immunology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan. 4) Division of Rheumatology, Department of Internal Medicine, Tokai University School of Medicine, Isehara, Japan. 5) Second Division, Department of Internal Medicine, Hamamatsu University School of Medicine, Hamamatsu, Japan. 6) Department of Respiratory Medicine and Allergy, Tosei General Hospital, Seto, Japan.
Publications: 
Expert Review of Respiratory Medicine
Document Types: , Article
Countries: , Japan
Abstract: https://www.tandfonline.com/doi/full/10.1080/17476348.2023.2176303
Condition Year Language Analysis type
, Respiratory disease 2023 English , Literature Review, Survey research
 
 
Exploring current practice, knowledge, and challenges of sexually transmitted infection/HIV management and pre-exposure prophylaxis among Japanese health care professionals: a cross-sectional web survey
Authors: Mayuko Kamakura 1, Daisuke Fukuda 1, Naho Kuroishi 1, Dilinuer Ainiwaer 2, Junko Hattori 1 (rwesheorj 2)
Affiliations: 1) Medical Affairs, MSD K.K., Tokyo, Japan 2) IQVIA Solutions Japan K.K., Tokyo, Japan
Publications: 
AIDS Patient Care and STDs
Document Types: , Article
Countries: , Japan
Abstract: https://www.liebertpub.com/doi/10.1089/apc.2023.0013
Condition Year Language Analysis type
, HIV AIDS 2023 English , Survey research
 
 
Comparison of depression trends in the Japanese and US populations before and during the COVID-19 pandemic: a retrospective observational study using real-world data
Authors: Sven Demiya 1, Shujiro Takeno 1, Louis P. Watanabe 1, Wen Shi Lee 1, Yuri Sakai 1, Todd D. Taylor 1, Seok-Won Kim 1 (rwesheorj 1)
Affiliations: 1) IQVIA Solutions Japan KK, Tokyo Japan
Publications: 
Value & Outcomes Spotlight
Document Types: , Article
Countries: , Japan, USA
Abstract: https://www.ispor.org/publications/journals/value-outcomes-spotlight/vos-archives/issue/view/mental-health-the-silent-pandemic/comparison-of-depression-trends-in-the-japanese-and-us-populations-before-and-during-the-covid-19-pandemic-a-retrospective-observational-study-using-real-world-data
Condition Year Language Analysis type
, Mental health 2023 English , Database Study, Observational study, Retrospective database analysis
 
 
Cost of illness: estimating direct healthcare costs related to obesity in a Japanese clinical setting
Authors: Riku Ota 1, Koki Idehara 2, Hiroyuki Matsuda 2, Ronald Filomeno 2, J Baker-Knight 3 (rwesheorj 2)
Affiliations: 1) Novo Nordisk Pharma Ltd., Nerima, 13, Japan 2) IQVIA Solutions Japan K.K., Minato-ku, Tokyo, Japan 3) Novo Nordisk, 2900, Denmark
Publications: 
ISPOR
Value in Health
Document Types: , Abstract, Conference, Poster, Presentation
Countries: , Japan
Abstract: https://www.ispor.org/heor-resources/presentations-database/presentation/intl2023-3669/124060
Condition Year Language Analysis type
, Endocrinology 2023 English , Cost of illness, Database Study
 
 
Real-world trends of patients with syphilis in Japan using integrated data of IQVIA Claims, JAST data and DeSC database
Authors: Yuki Kado 1, Seok-Won Kim 2, T Ishii 3 (rwesheorj 1-3)
Affiliations: 1) IQVIA Solutions Japan, Minato-ku, 13, Japan 2) IQVIA Solutions Japan, Minato, 13, Japan 3) IQVIA Solutions Japan, Minato-ku, Tokyo, Japan
Publications: 
ISPOR
Value in Health
Document Types: , Abstract, Conference, Poster, Presentation
Countries: , Japan
Abstract: https://www.ispor.org/heor-resources/presentations-database/presentation/intl2023-3668/124021
Condition Year Language Analysis type
, Infectious disease 2023 English , Database Study
 
 
Real-world clinical practice of pulmonary arterial hypertension in Japan: Insights from a large administrative database
Authors: Junichi Omura 1, Kazuki Kitahara 1, Masashi Takano 1, Koki Idehara 2, Seok-Won Kim 2 (rwesheorj 2)
Affiliations: 1) Medical Affairs Janssen Pharmaceutical K. K. Tokyo Japan 2) RWES/HEOR IQVIA Solutions Japan K. K. Tokyo Japan
Publications: 
Pulmonary Circulation
Document Types: , Article
Countries: , Japan
Abstract: https://onlinelibrary.wiley.com/doi/10.1002/pul2.12275
Condition Year Language Analysis type
, Cardiovascular disease 2023 English , Database Study, Retrospective cohort analysis
 
 
Comparative effectiveness of sodium-glucose co-transporter-2 inhibitors and dipeptidyl peptidase-4 inhibitors on liver function in patients with type 2 diabetes in Japan: a real-world data analysis
Authors: Hirokazu Takahashi 1 2, Keiko Asakawa 3, Yoshinori Kosakai 3, Takumi Lee 3, Mitsuhiro Rokuda 3 (rwesheorj A)
Affiliations: 1) Liver Center, Saga University Hospital, Saga, Japan 2) Division of Metabolism and Endocrinology, Faculty of Medicine, Saga University, Saga, Japan 3) Astellas Pharma Inc., Tokyo, Japan
Publications: 
Diabetes Obesity and Metabolism
Document Types: , Article, Online article
Countries: , Japan
Abstract: https://dom-pubs.pericles-prod.literatumonline.com/doi/10.1111/dom.15399
Condition Year Language Analysis type
, Diabetes 2023 English , Database Study, Retrospective cohort analysis
 
 
Patient and therapeutic profiles of pulmonary hypertension in chronic lung diseases in Japan: a cohort study using a claims database
Authors: Kazuki Kitahara 1, Junichi Omura 2, Shingo Wada 3, Seok-Won Kim 3 (rwesheorj 3)
Affiliations: 1) Medical Affairs, Janssen Pharmaceutical K.K., 3-5-2 Nishikanda, Chiyoda-ku, Tokyo, 101-0065, Japan. kkitahar@its.jnj.com 2) Medical Affairs, Janssen Pharmaceutical K.K., 3-5-2 Nishikanda, Chiyoda-ku, Tokyo, 101-0065, Japan 3) Real World Evidence Solutions, IQVIA Solutions Japan K.K., 4-10-18 Takanawa, Minato-ku, Tokyo, 108-0074, Japan
Publications: 
Pulmonary Therapy
Document Types: , Article, Online article
Countries: , Japan
Abstract: https://link.springer.com/article/10.1007/s41030-023-00243-x
Condition Year Language Analysis type
, Cardiovascular disease, Respiratory disease 2023 English , Database Study, Retrospective cohort analysis
 
 
Empagliflozin cost-effectiveness analysis in Japanese heart failure with mildly reduced and preserved ejection fraction
Authors: Hiroyuki Tsutsui 1 2, Hiroyuki Sakamaki 3, Shin-Ichi Momomura 4, Yasushi Sakata 5, Yutaro Kotobuki 6, Stephan Linden 7, Koki Idehara 8, Daisuke Nitta 6 (rwesheorj 8)
Affiliations: 1) School of Medicine and Graduate School, International University of Health and Welfare, Tokyo, Japan 2) Department of Cardiovascular Medicine, Faculty of Medical Sciences, Kyushu University, Fukuoka, Japan 3) Kanagawa University of Human Services, School of Health Innovation, Kawasaki, Japan 4) Saitama Citizens Medical Centre, Saitama, Japan 5) Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine, Osaka, Japan 6) Medicine Division, Nippon Boehringer Ingelheim Co., Ltd., Shinagawa, Tokyo, Japan 7) Boehringer Ingelheim International GmbH, Ingelheim am Rhein, Germany 8) Real World Evidence Solutions & HEOR, IQVIA Solutions Japan K.K., Tokyo, Japan
Publications: 
ESC Heart Failure
Document Types: , Article, Online article
Countries: , Japan
Abstract: https://onlinelibrary.wiley.com/doi/10.1002/ehf2.14565
Condition Year Language Analysis type
, Cardiovascular disease 2023 English , Cost analysis
 
 
A real-world, retrospective, observational study examining treatment patterns and clinical outcomes in patients with FLT3m + AML in Japan
Authors: Toru Kiguchi 1, Masaya Sakurai 2, Yusuke Tanaka 2, Kazuyuki Kuramoto 2, Yuki Kado 3, Sono Sawada 3, Takeshi Mitomi 2 (rwesheorj 3)
Affiliations: 1) Dokkyo Medical University Saitama Medical Center, Saitama, Japan 2) Astellas Pharma Inc., Tokyo, Japan 3) IQVIA Solutions Japan K.K., Tokyo, Japan
Publications: 
Current Medical Research and Opinion
Document Types: , Abstract, Online article
Countries: , Japan
Abstract: https://www.tandfonline.com/doi/full/10.1080/03007995.2023.2271390
Condition Year Language Analysis type
, Oncology 2023 English , Database Study, Retrospective cohort analysis
 
 
Burden of caregivers of patients with neuronopathic and non-neuronopathic Gaucher disease in Japan: a survey-based study
Authors: Yuta Koto 1, Aya Narita 2, Shinichi Noto 3, Masafumi Okada 4, Midori Ono 5, Terumi Baba 5, Rieko Sagara 5, Norio Sakai 1 (rwesheorj 4)
Affiliations: 1) Child Healthcare and Genetic Science Laboratory, Division of Health Sciences, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita-shi, Osaka 565-0871, Japan 2) Division of Child Neurology, Institute of Neurological Science, Tottori University Faculty of Medicine, 86 Nishi-cho, Yonago-shi, Tottori 683-8503, Japan 3) Department of Rehabilitation, Niigata University of Health and Welfare, 1398 Shimami-cho, Kita-ku, Niigata-shi, Niigata 950-3198, Japan 4) Real-World Evidence Solutions & HEOR, IQVIA Solutions Japan K.K., 4-10-18 Takanawa, Minato-ku, Tokyo 108-0074, Japan 5) Japan Medical Office, Takeda Pharmaceutical Company Limited, 2-1-1 Nihonbashi-Honcho, Chuo-ku, Tokyo 103-8688, Japan
Publications: 
Molecular Genetics and Metabolism Reports
Document Types: , Article, Online article
Countries: , Japan
Abstract: https://www.sciencedirect.com/science/article/pii/S221442692300040X?via%3Dihub
Condition Year Language Analysis type
, Endocrinology, Neurological disorders 2023 English , Patient questionnaire, Survey research
 
 
Health-related quality of life in patients with alopecia areata: Results of a Japanese survey with norm-based comparisons
Authors: Taisuke Ito 1, Kazumasa Kamei 2, Akira Yuasa 3, Fumihiro Matsumoto 2, Yayoi Hoshi 4, Masafumi Okada 4, Shinichi Noto 5 (rwesheorj 4)
Affiliations: 1) Department of Dermatology, Hamamatsu University School of Medicine, Hamamatsu, Japan 2) Inflammation and Immunology Medical Affairs, Pfizer Japan Inc., Tokyo, Japan 3) Health and Value, Pfizer Japan Inc., Tokyo, Japan 4) Real-World Evidence Solutions & HEOR, IQVIA Solutions Japan K.K., Tokyo, Japan
Publications: 
The Journal of Dermatology
Document Types: , Article
Countries: , Japan
Abstract: https://onlinelibrary.wiley.com/doi/full/10.1111/1346-8138.16364
Condition Year Language Analysis type
, Dermatology, Mental health 2022 English , Patient questionnaire, Quality of life, Survey research
 
 
Physician awareness and understanding of hereditary angioedema: a web-based study in Japan
Authors: Atsushi Fukunaga 1,2, Miwa Kishimoto 3*, Akinori Oh 3, Takeshi Akiyama 4, Ippei Kotera 3, Yoichi Inoue 3, Junichi Maehara 5 (rwesheorj 4)
Affiliations: 1) Division of Dermatology, Department of Internal Related, Kobe University Graduate School of Medicine, Hyogo, Japan 2) Division of Medicine for Function and Morphology of Sensory Organs, Department of Dermatology, Faculty of Medicine, Osaka Medical and Pharmaceutical University, Takatsuki, Japan 3) Japan Medical Office, Takeda Pharmaceutical Company Limited, Tokyo, Japan 4) Real World Evidence Solutions & HEOR, IQVIA Solutions Japan K.K., Tokyo, Japan 5) Department of Acute Care and General Medicine, Emergency and Critical Care Center, Saiseikai Kumamoto Hospital, Kumamoto, Japan
Publications: 
Journal of Cutaneous Immunology and Allergy.
Document Types: , Article
Countries: , Japan
Abstract: https://onlinelibrary.wiley.com/doi/10.1002/cia2.12265
Condition Year Language Analysis type
, Rare disease 2022 English , Survey research
 
 
Cost-effectiveness of vonoprazan compared with proton pump Inhibitors in patients taking low-dose aspirin for secondary prevention of cardiovascular events in Japan
Authors: Masanobu Ishii 1, Takashi Kawai 2, Kenichi Tsujita 3*, Ataru Igarashi 4, Manabu Suzuki 5, Hisato Deguchi 5, Jovelle Fernandez 5 (rwesheorj A)
Affiliations: 1) Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University, Japan 2) Department of Gastroenterological Endoscopy, Tokyo Medical University, Japan 3) Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University, Japan 4) Department of Health Economics and Outcomes Research, Graduate School of Pharmaceutical Sciences, The University of Tokyo, Japan 5) Japan Medical Office, Takeda Pharmaceutical Company Limited, Japan
Publications: 
Circulation Journal
Document Types: , Article
Countries: , Japan
Abstract: https://www.jstage.jst.go.jp/article/circj/advpub/0/advpub_CJ-22-0127/_html/-char/en
Condition Year Language Analysis type
, Cardiovascular disease 2022 English , Cost effectiveness
 
 
Development of a clinical prediction model for recurrence and mortality outcomes after Clostridioides difficile infection using a machine learning approach
Authors: Daniel Ruzicka 1, Takayuki Kondo 1, Go Fujimoto 1, Andrew P.Craig 2, Seok-Won Kim 2, Hiroshige Mikamo 3 (rwesheorj 2)
Affiliations: 1) Medical Affairs, MSD K.K., Tokyo, Japan, Kitanomaru Square, 1-13-12 Kudan-kita, Chiyoda-ku, Tokyo, 102-8667, Japan 2) Real World Evidence Solutions, IQVIA Solutions Japan K.K., Takanawa 4-10-18, Minato-ku, Tokyo, 108-0074, Japan 3) Department of Clinical Infectious Diseases, Aichi Medical University Graduate School of Medicine, 1-1, Yazakokarimata, Nagakute, Aichi, 480-1195, Japan
Publications: 
Anaerobe
Document Types: , Article
Countries: , Japan
Abstract: https://www.sciencedirect.com/science/article/abs/pii/S1075996422001214?via%3Dihub
Condition Year Language Analysis type
, Infectious disease 2022 English , Methodology
 
 
Assessing the correlation between second progression-free survival (PFS2) and overall survival (OS) in advanced prostate cancer patients using medical data vision (MDV) claims database in Japan
Authors: Masaki Shiota 1, Raf De Moor 2, Yosuke Koroki 2, Dae Young Yu 3, David Bin-Chia Wu 4 (rwesheorj A)
Affiliations: 1) Department of Urology, Graduate School of Medical Sciences, Kyushu University Hospital, Fukuoka, Japan 2) Integrated Market Access, Janssen Pharmaceutical KK, Tokyo, Japan 3) Janssen Pharmaceutical Companies of Johnson and Johnson, Asia Pacific Regional Office, Singapore, Singapore 4) Janssen Pharmaceutical Companies of Johnson and Johnson, Asia Pacific Regional Office, Singapore, Singapore;e Saw Swee Hock School of Public Health, National University of Singapore, Singapore, Singapore;f School of Pharmacy, Monash University Malaysia, Bandar Sunway, Malaysia
Publications: 
Current Medical Research and Opinion
Document Types: , Article
Countries: , Japan
Abstract: https://www.tandfonline.com/doi/full/10.1080/03007995.2022.2096353
Condition Year Language Analysis type
, Oncology 2022 English , Database Study
 
 
Impact of refractory and unexplained chronic cough on disease burden: a qualitative study
Authors: Naoya Ueda 1, Anzu Yakushiji 2, Jonathan Schelfhout 3, Shigeru Tokita 1, Takekazu Kubo 4* (rwesheorj 2)
Affiliations: 1) Medical Affairs, MSD K.K., Tokyo, Japan 2) IQVIA Solutions Japan K.K., Tokyo, Japan 3) Merck & Co Inc, Rahway, NJ, USA 4) Medical Affairs, MSD K.K., Tokyo, Japan
Publications: 
BMC Pulmonary Medicine
Document Types: , Article
Countries: , Japan
Abstract: https://bmcpulmmed.biomedcentral.com/articles/10.1186/s12890-022-02171-z
Condition Year Language Analysis type
, Respiratory disease 2022 English , Burden of illness, Patient questionnaire
 
 
Thrombotic and cardiovascular events and treatment patterns among patients hospitalized with COVID-19 in Japan: an analysis of a nationwide medical claims database
Authors: Naoki Terasaka 1*, Yukako Matsuo 2, Hirohide Kataoka 2, Yasuhiko Miyata 2, Yoshio Anazawa 2 (rwesheorj A)
Affiliations: 1) Medical Department, Bristol Myers Squibb K.K., Tokyo, Japan 2) Medical Department, Bristol Myers Squibb K.K., Tokyo, Japan
Publications: 
Cardiology and Therapy
Document Types: , Article
Countries: , Japan
Abstract: https://link.springer.com/article/10.1007/s40119-022-00263-9
Condition Year Language Analysis type
, Cardiovascular disease, COVID-19 2022 English , Database Study
 
 
Patients' preferences for attributes of molecular targeting therapies for advanced non-small cell lung cancer with EGFR mutations in Japan - a discrete-choice experiment
Authors: Kazuhiko Nakagawa 1, Yoshinori Tanizawa 2, Zhihong Cai 2, Tomoko Matsui 2, Sotaro Enatsu 2 (rwesheorj A)
Affiliations: 1) Kindai University, Department of Medical Oncology, Kindai University Faculty of Medicine, Osaka, Japan 2) Eli Lilly Japan K.K., Japan Drug Development and Medical Affairs, Kobe, Japan
Publications: 
Japanese Journal of Cancer and Chemotherapy
Document Types: , Article
Countries: , Japan
Abstract: https://www.pieronline.jp/content/article/0385-0684/49120/1329
Condition Year Language Analysis type
, Oncology 2022 Japanese , Patient questionnaire
 
 
Budget impact analysis of next-generation sequencing versus sequential single-gene testing in Japanese patients with advanced non-small-cell lung cancer
Authors: Hiroyuki Matsuda 1, Toru Ogawa 2*, Yasunari Sadatsuki 3, Toshiaki Tsujino 3, Shingo Wada 1, Seok-Won Kim 1, Yutaka Hatanaka 4 (rwesheorj 1)
Affiliations: 1) Real World Evidence Solutions & HEOR, IQVIA Solutions Japan K.K., Tokyo, Japan 2) Market Access Oncology, Bayer Yakuhin, Ltd, Osaka, Japan 3) Medical Affairs & Pharmacovigilance, Bayer Yakuhin, Ltd, Osaka, Japan 4) Research Division of Genome Companion Diagnostics, Hokkaido University Hospital, Hokkaido, Japan
Publications: 
Respiratory Investigation
Document Types: , Article
Countries: , Japan
Abstract: https://www.sciencedirect.com/science/article/pii/S2212534522001435?via%3Dihub
Condition Year Language Analysis type
, Oncology 2022 English , Budget impact, Database Study
 
 
Characteristics of Japanese patients with non-dialysis-dependent chronic kidney disease initiating treatment for anemia: a retrospective real-world database study
Authors: Yoshimasa Kokado 1*, Manabu Ishii 1, Kiichiro Ueta 1, Hiroyuki Yamamoto 2, Hiraku Kumamaru 3, Masaaki Isshiki 4, Sven Demiya 4, Hiroaki Miyata 2 (rwesheorj 4)
Affiliations: 1) Integrated Value Development Division, Mitsubishi Tanabe Pharma Corporation, Tokyo, Japan 2) Department of Health Policy and Management, School of Medicine, Keio University, Tokyo, Japan 3) Department of Healthcare Quality Assessment, Graduate School of Medicine, University of Tokyo, Tokyo, Japan 4) Real World Data Consulting, IQVIA Solutions Japan KK, Tokyo, Japan
Publications: 
Current Medical Research and Opinion
Document Types: , Article
Countries: , Japan
Abstract: https://www.tandfonline.com/doi/full/10.1080/03007995.2022.2125256
Condition Year Language Analysis type
, Nephrology 2022 English , Database Study
 
 
Physician awareness and understanding of primary immunodeficiency disorders: a web-based study in Japan
Authors: Kohsuke Imai 1, Akinori Oh 2, Ayumi Morishita 3, Yoichi Inoue 2* (rwesheorj 3)
Affiliations: 1) Department of Pediatrics, National Defense Medical College, Tokorozawa, Japan 2) Japan Medical Office, Takeda Pharmaceutical Company Limited, Tokyo, Japan 3) IQVIA Solutions Japan K.K, Tokyo, Japan
Publications: 
Immunological Medicine
Document Types: , Article
Countries: , Japan
Abstract: https://www.tandfonline.com/doi/full/10.1080/25785826.2022.2137966
Condition Year Language Analysis type
, Immunology and Vaccination 2022 English , Survey research
 
 
Impact of refractory and unexplained chronic cough on disease burden: a qualitative study
Authors: Naoya Ueda 1, Anzu Yakushiji 2, Jonathan Schelfhout 3, Shigeru Tokita 1, Takekazu Kubo 1* (rwesheorj 2)
Affiliations: 1) MSD Co., Ltd., Medical Affairs 2) IQVIA Solutions Japan K.K., Tokyo, Japan 3) Merck & Co Inc, Kenilworth, New Jersey, USA
Publications: 
The 62nd Annual Meeting of the Japanese Respiratory Society
Document Types: , Conference, Poster, Presentation
Countries: , Japan
Abstract: https://www.jrs.or.jp/jrs62/index.html
Condition Year Language Analysis type
, Respiratory disease 2022 Japanese , Patient questionnaire
 
 
Real picture of patients with Charcot-Marie-Tooth disease in Japan: IQVIA Claims Database
Authors: Yuki Kado 1, Yuya Tamai 1, Seok-Won Kim 1, Sven Demiya 1 (rwesheorj 1)
Affiliations: 1) Real World Evidence Solutions & HEOR, IQVIA Solutions Japan K.K., Tokyo, Japan
Publications: 
ISPOR
Document Types: , Conference, Poster, Presentation
Countries: , Japan
Abstract: https://www.valueinhealthjournal.com/article/S1098-3015(22)01125-1/fulltext
Condition Year Language Analysis type
, Neurological disorders 2022 English , Database Study
 
 
Prevalence of depression in Japan and the US populations before and during the COVID-19 pandemic: a retrospective observational study using real-world data
Authors: Demiya S 1, Takeno S 1, Kim SW 2, Lee WS 3, Sakai Y 1 (rwesheorj 1-3)
Affiliations: 1) IQVIA Solutions Japan, Tokyo, Japan 2) IQVIA Solutions Japan, Tokyo, 13, Japan 3) IQVIA Solutions Japan, Tokyo, 12, Japan
Publications: 
ISPOR Europe
Document Types: , Conference, Poster, Presentation
Countries: , Japan, USA
Abstract: https://www.ispor.org/heor-resources/presentations-database/presentation/euro2022-3564/119994
Condition Year Language Analysis type
, Mental health 2022 English , Database Study, Retrospective database analysis
 
 
Characteristics, treatment patterns, and healthcare costs of advanced/metastatic biliary tract cancer patients in Japan
Authors: CC Chen 1, X Wang 1, Seok-Won Kim 2*, Shingo Wada 2, J Garside 3, ES Reese 4 (rwesheorj 2)
Affiliations: 1) IQVIA, Plymouth Meeting, PA, USA 2) IQVIA, Tokyo, Japan 3) GlaxoSmithKline, London, UK 4) EMD Serono Research & Development Institute, Inc, Billerica, MA, USA, an affiliate of Merck KGaA
Publications: 
Japanese Society of Medical Oncology Annual Meeting
Document Types: , Conference, Oral presentation
Countries: , Japan
Abstract: https://www.c-linkage.co.jp/jsmo2022/en/index.html
Condition Year Language Analysis type
, Oncology 2022 English , Database Study
 
 
Prognosis of lung cancer patients treated with immune checkpoint inhibitors with or without antimicrobial history
Authors: Ryohei Kobayashi 1, Kenji Kanagawa 1, Sanesue Yasukawa 1, Takuma Kondo 1, Shingo Wada 2 (rwesheorj 2)
Affiliations: 1) IQVIA Services Japan K.K. 2) IQVIA Solutions Japan K.K.
Publications: 
The 27th Annual Meeting of the Japanese Society for Pharmacoepidemiology
Document Types: , Conference, Oral presentation
Countries: , Japan
Abstract: https://www.jspe.jp/meeting/soukai/272022.html
Condition Year Language Analysis type
, Oncology 2022 Japanese , Database Study, Retrospective cohort analysis
 
 
Database study on background information and first-line drug treatment of patients with early-onset Alzheimer's disease
Authors: Shingo Wada 1, Ryosuke Miyagawa 2, Ai Inada 2, Yugo Namiya 2, Komei Iwasaki 2, Ryohei Kobayashi 2, Kaiwei Yan 1 (rwesheorj 1)
Affiliations: 1) IQVIA Solutions Japan K.K. 2) IQVIA Services Japan K.K.
Publications: 
The 27th Annual Meeting of the Japanese Society for Pharmacoepidemiology
Document Types: , Conference, Oral presentation
Countries: , Japan
Abstract: https://www.jspe.jp/meeting/soukai/272022.html
Condition Year Language Analysis type
, Neurological disorders 2022 Japanese , Database Study
 
 
Budget impact analysis of Jivi® (damoctocog alfa pegol, BAY 94-9027) in severe Hemophilia A in Japan
Authors: Teruhisa Fujii 1, Yuko Kidoguchi 2, Noriko Takahashi 2, Eric Yu 3, Dilinuer Ainiwaer 3, Aidan Byrne 4 (rwesheorj 3)
Affiliations: 1) Division of Blood Transfusion, Hiroshima University Hospital, Hiroshima, Japan 2) Market Access, Bayer Yakuhin, Ltd., Tokyo, Japan 3) IQVIA Solutions Japan K.K., Tokyo, Japan 4) IQVIA UK, London, UK
Publications: 
Journal of Medical Economics
Document Types: , Article
Countries: , Japan
Abstract: https://www.tandfonline.com/doi/full/10.1080/13696998.2021.1875788
Condition Year Language Analysis type
, Health economics 2021 English , Budget impact
 
 
Real-world treatment and health care resource use among severe asthma patients in Japan
Authors: Yasuo To 1, Yurie Taguchi 2, Tatsuya Shimazaki 2, Kazuhiko Arima 2, Eric Yu 3, Sven Demiya 3, Takashi Iwanaga 4 (rwesheorj 3)
Affiliations: 1) Department of Pulmonary Medicine, International University of Health and Welfare, School of Medicine, 1-4-3 Mita, Minato-ku, Tokyo 108-8329, Japan 2) Sanofi K.K., 3-20-2 Nishi Shinjuku, Shinjuku-ku, Tokyo 163-1488, Japan 3) IQVIA Solutions Japan K.K., Keikyu Dai-7 Building 4-10-8, Takanawa Minato-ku, Tokyo 108-0074, Japan 4) Kindai University, 377-2 Ohno Higashi, Osakasayama City, Osaka 589-8511, Japan
Publications: 
Respiratory Investigation
Document Types: , Article
Countries: , Japan
Abstract: https://www.sciencedirect.com/science/article/abs/pii/S2212534521000423?via%3Dihub
Condition Year Language Analysis type
, Clinical practice 2021 English , Database Study
 
 
Cost-effectiveness analysis of the treatment strategies with or without opioid medications in surgery-eligible patients with osteoarthritis in Japan
Authors: Tomoyuki Takura 1, Akira Yuasa 2, Naohiro Yonemoto 2, Sven Demiya 3, Hiroyuki Matsuda 3, Nozomi Ebata 4, Koichi Fujii 4, Muneaki Ishijima 5 (rwesheorj 3)
Affiliations: 1) Department of Healthcare Economics and Health Policy, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan 2) Health and Value, Pfizer Japan Inc., Shinjuku Bunka Quint Building, 3-22-7, Yoyogi, Shibuya-ku, Tokyo, 151-8589, Japan 3) IQVIA Solutions Japan K.K., Tokyo, Japan 4) Medical Affairs, Pfizer Japan Inc, Tokyo, Japan 5) Department of Medicine for Orthopaedics and Motor Organ, Juntendo University Graduate School of Medicine, Tokyo, Japan
Publications: 
PharmacoEconomics - Open
Document Types: , Article
Countries: , Japan
Abstract: https://link.springer.com/article/10.1007/s41669-021-00292-5
Condition Year Language Analysis type
, Health economics 2021 English , Cost effectiveness, Literature Review
 
 
Healthcare resource utilization and economic burden of antifungal management in patients with hematologic malignancy in Japan: a retrospective database study
Authors: Rie Ueno 1, Shinichi Nishimura 1, Go Fujimoto 1, Dilinuer Ainiwaer 2 (rwesheorj 2)
Affiliations: 1) MSD K.K, Tokyo, Japan 2) IQVIA Solutions Japan K.K., Tokyo, Japan
Publications: 
Current Medical Research and Opinion
Document Types: , Article
Countries: , Japan
Abstract: https://www.tandfonline.com/doi/full/10.1080/03007995.2021.1927691
Condition Year Language Analysis type
, Infectious disease 2021 English , Database Study
 
 
An exploratory assessment of the applicability of direct-to-consumer genetic testing to translational research in Japan
Authors: Masahiro Inoue 1, Shota Arichi 1, Tsuyoshi Hachiya 1, Anna Ohtera 2, Seok-Won Kim 2, Eric Yu 2, Masatoshi Nishimura 3, Kazuhito Shiosakai 3, Takeshi Ohira 3 (rwesheorj 2)
Affiliations: 1) HealthData Lab, Yahoo! Japan Corporation, Kioi Tower, Tokyo Garden Terrace Kioicho, 1-3, Kioi-cho, Chiyoda-ku, Tokyo, 102-8282, Japan 2) Real World Evidence Solutions, IQVIA Solutions Japan K.K, Takanawa 4-10-18, Minato-ku, Tokyo, 108-0074, Japan 3) Daiichi Sankyo Co. Ltd, Tokyo, Japan
Publications: 
BMC Research Notes
Document Types: , Article
Countries: , Japan
Abstract: https://bmcresnotes.biomedcentral.com/articles/10.1186/s13104-021-05696-4
Condition Year Language Analysis type
, Database Validity and methodology 2021 English , Methodology, Patient questionnaire, Real World Evidence, Survey research
 
 
Patient preferences for growth hormone treatment in Japanese children
Authors: Toshiaki Tanaka 1, Takahiro Sato 2, Akira Yuasa 3, Takeshi Akiyama 4, Adeeb Tawseef 4 (rwesheorj 4)
Affiliations: 1) Tanaka Growth Clinic, Tokyo, Japan 2) Medical Affairs, Rare Disease, Pfizer Japan Inc, Tokyo, Japan 3) Corporate Affairs, Health and Value, Pfizer Japan Inc, Tokyo, Japan 4) IQVIA Solutions Japan K.K., RWE & HEOR, Tokyo, Japan
Publications: 
Pediatrics International
Document Types: , Article
Countries: , Japan
Abstract: https://onlinelibrary.wiley.com/doi/epdf/10.1111/ped.14760
Condition Year Language Analysis type
, Endocrinology 2021 English , Patient questionnaire, Survey research
 
 
COVID-19 patients analysis utilizing Japan and US claims databases
Authors: Seok-Won Kim 1, T Ishii 2, Shujiro Takeno 2, Yuki Kado 2, Yuya Tamai 2, Takeshi Akiyama 2, Eric Yu 2, Sven Demiya 2 (rwesheorj 1-2)
Affiliations: 1,2) IQVIA Solutions Japan, Minato-ku, Tokyo, Japan
Publications: 
ISPOR 2021 Conference
Document Types: , Conference, Poster, Presentation
Countries: , Japan
Abstract: https://www.ispor.org/heor-resources/presentations-database/presentation/intl2021-3340/111047
Condition Year Language Analysis type
, COVID-19 2021 English , Database Study
 
 
COVID-19 patient severities in Japanese EMR
Authors: Masafumi Okada 1, Shingo Wada 1, Masaaki Isshiki 2, Sadako Utsunomiya 2, Takeshi Akiyama 1, Kenji Hamada 1, Sven Demiya 1 (rwesheorj 1)
Affiliations: 1,2) IQVIA Solutions Japan K.K., Minato-ku, Tokyo, Japan
Publications: 
ISPOR 2021 Conference
Document Types: , Conference, Poster, Presentation
Countries: , Japan
Abstract: https://www.ispor.org/heor-resources/presentations-database/presentation/intl2021-3340/111009
Condition Year Language Analysis type
, COVID-19 2021 English , Database Study
 
 
Risk Factors and Medical Resource Utilization of Respiratory Syncytial Virus, Human Metapneumovirus and Influenza Related Hospitalizations in Adults – A Global Study During the 2017-2019 Epidemic Seasons (Hospitalized Acute Respiratory Tract Infection [HARTI] Study)
Authors: Ann R Falsey, Edward E Walsh, Stacey House, Yannick Vandenijck, Xiaohui Ren, Sofia Keim, Diye Kang, Pascale Peeters, James Witek, Gabriela Ispas
Affiliations: University Of Rochester School Of Medicine and Rochester Regional Health, Rochester, NY, United States; Washington University School of Medicine, St Louis, MO, United States; Janssen Infectious Diseases, Beerse, Belgium; IQVIA Real-World Solutions, Courbevoie, France; Janssen Research & Development, LLC, Titusville, NJ, United States
Publications: 
Document Types: , Article
Countries: , Argentina, Australia, Brazil, Canada, France, Germany, Japan, Korea, Malaysia, Mexico, South Africa, USA
Abstract: https://academic.oup.com/ofid/advance-article/doi/10.1093/ofid/ofab491/6381446
Condition Year Language Analysis type
, Infectious disease 2021 English , Burden of illness, Clinical setting: hospital, Epidemiological study, Observational study, Patient questionnaire, Prospective study
 
 
Real-World Profiling of Non-Small Cell Lung Cancer Patients in Japan
Authors: Elaine Chang Takahashi 1, Shiho Wakase 2, Masayuki Ito 1, Todd D Taylor 3 (rwesheorj 3)
Affiliations: 1) Novartis Pharma K.K., Minato-ku, Japan 2) Novartis Pharma K.K., Tokyo, Japan 3) IQVIA Solutions Japan K.K., Minato-ku, Tokyo, Japan
Publications: 
ISPOR Europe 2021
Document Types: , Conference, Poster, Presentation
Countries: , Japan
Abstract: https://www.ispor.org/heor-resources/presentations-database/presentation/euro2021-3407/111943
Condition Year Language Analysis type
, Oncology 2021 English , Database Study, Real World Evidence
 
 
Descriptive study on burden and communication of fatigue among castration-resistant prostate cancer patients in Japan
Authors: Taro Iguchi 1, Yusuke Nakamura 2, Takeshi Akiyama 3, Krishant Chand 3, Eric Yu 3 (rwesheorj 3)
Affiliations: 1) Department of Urology, Kanazawa Medical University 2) Market and Regional Access, Bayer Yakuhin, Ltd 3) Real World Evidence Solutions, IQVIA Solutions Japan K.K.
Publications: 
Current Medical Research and Opinion
Document Types: , Article
Countries: , Japan
Abstract: https://www.tandfonline.com/doi/full/10.1080/03007995.2021.2006534
Condition Year Language Analysis type
, Oncology 2021 English , Burden of illness, Observational study, Patient questionnaire, Population Based Study, Real World Evidence, Survey research
 
 
Effectiveness and safety of empagliflozin in routine care in Europe and East Asia: results from the empagliflozin comparative effectiveness and safety (EMPRISE) study
Authors: A. Karasik1 , S. Lanzinger2 , E. Chia-Hui Tan3 , D. Yabe4 , D. Jung Kim5 , W. H-H Sheu6 , C. MelzerCohen1 , R.W. Holl2 , K. Ha5 , T. Nyström7 , L. Niskanen8 , M. Linnemann Jensen9 , M.H. Kyaw10, J. Núñez11, EMPRISE EU and East Asia Study Group;
Affiliations: Maccabi Research & Innovation Center, Tel Aviv University, Tel Aviv, Israel, 2 Inst. for Epidemiology & Medical Biometry, Uni. of Ulm, Ulm, Germany, 3National Research Inst. of Chinese Medicine, Taipei, Taiwan, 4Dept. of Diabetes and Endocrinology, Gifu University Graduate School of Medicine, Gifu, Japan, 5Dept. of Endocrinology & Metabolism, Ajou Uni. School of Medicine, Suwon, Republic of Korea, 6Taipei Veterans General Hospital, Taipei, Taiwan, 7Dept. of Clinical Science & Education, Södersjukhuset, Karolinska Institutet, Solna, Sweden, 8Department of Medicine, Päijät-Häme Central Hospital, Lahti, Finland, 9 IQVIA, Copenhagen, Denmark, 10Boehringer Ingelheim Pharmaceutical Inc., Ridgefield, USA, 11Dept. of Cardiology, Hospital Clínico Universitario de Valencia, Valencia, Spain
Publications: 
https://doi.org/10.2337/DB21-127-LB
Virtual EASD 2021, 57 Annual Meeting, 27 September - 10 October 2021
Document Types: , Abstract
Countries: , Finland, Germany, Israel, Japan, South Korea, Spain, Sweden, Taiwan
Abstract: https://easddistribute.m-anage.com/from.storage?image=gOIMdpw6-DbPpKIQZ5HFcJGqJ2quHgbqFewkkUQkLblXdwzJ9kfmAYikI6R6NFu_GLAQJwEZKsC1PXU8ndyryA2
Condition Year Language Analysis type
, Cardiovascular disease, Diabetes 2021 English , Database Study, Methodology, Population Based Study
 
 
Cardiovascular Effectiveness of Empagliflozin Compared to DPP-4i in Routine Care in East Asia: Results from the EMPRISE study
Authors: Dae Jung Kim, Wayne H.-H. Sheu, Wook-Jin Chung, Daisuke Yabe, Kyoung Hwa Ha, Elise Chia-Hui Tan, Yusuke Taneda, Vanessa Lei, Laura Saarelainen, Anouk Deruaz-Luyet, Moe H. Kyaw, Yutaka Seino, EMPRISE East Asia Study Group, Boehringer Ingelheim International GmbH, Ingelheim, Germany, StatFinn - EPID Research an IQVIA Company, Espoo, Finland
Affiliations: 1 Ajou University, Suwon, South Korea; 2 Taichung Veterans General Hospital, Taichung, Taiwan; 3 Gachon University Gil Medical Center, Incheon, South Korea; 4 Kansai Electric Power Medical Research Institute, Kobe, Japan; 5 Gifu University Graduate School of Medicine, Gifu, Japan; 6 National Research Institute of Chinese Medicine, Taipei, Taiwan; 7 Nippon Boehringer Ingelheim Co. Ltd., Tokyo, Japan; 8 Boehringer Ingelheim Taiwan Ltd., Taipei, Taiwan; 9 IQVIA, Espoo, Finland; 10 Boehringer Ingelheim International GmbH, Ingelheim, Germany; 11 Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, USA; 12 Kansai Electric Power Hospital, Osaka, Japan
Publications: 
J Am Coll Cardiol. 2021 May, 77 (18_Supplement_1) 542. https://doi.org/10.1016/S0735-1097(21)01901-X
Document Types: , Abstract, Presentation
Countries: , Japan, South Korea, Taiwan
Abstract: https://www.jacc.org/doi/epdf/10.1016/S0735-1097%2821%2901901-X
Condition Year Language Analysis type
, Cardiovascular disease, Diabetes 2021 English , Database Study, Methodology, Observational study
 
 
The background occurrence of selected clinical conditions prior to the start of an extensive national vaccination program in Japan
Authors: Tomotaka Sobue 1 2, Haruhisa Fukuda 3, Tetsuya Matsumoto 4, Bennett Lee 5, Shuhei Ito 5*, Satoshi Iwata 6 (rwesheorj A)
Affiliations: 1) Division of Environmental Medicine and Population Science, Graduate School of Medicine, Osaka University, Osaka, Japan 2) Keio University School of Medicine, Tokyo, Japan 3) Department of Health Care Administration and Management, Kyushu University, Fukuoka, Japan 4) Department of Infectious Diseases, International University of Health and Welfare, Narita, Japan 5) Vaccine Medical Affairs, Pfizer Japan Inc., Tokyo, Japan 6) Department of Infectious Diseases, National Cancer Center Hospital, Tokyo, Japan
Publications: 
PLOS One
Document Types: , Article
Countries: , Japan
Abstract: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0256379
Condition Year Language Analysis type
, COVID-19, Immunology and Vaccination 2021 English , Database Study, Literature Review
 
 
The Burden Of Hpv In Head And Neck Cancers - Design Of The Broaden Study
Authors: Gómez Ulloa D1, Morais E2, Fenoll R1, Kothari S3, Giuliano A4, Mirghani H5, Mehanna H6, Waterboer T7, Roberts C3, Varga S3, Tu Y3, Pérez G3, Saah A3, Alemany L8
Affiliations: 1 IQVIA, Barcelona, Spain 2 MSD, CORE, Lyon, France 3 Merck & Co. Inc., Center for Observational and Real-world Evidence, Kenilworth, NJ, US 4 Moffitt Cancer Center and Research Institute, Center for Immunization and Infection Research in Cancer, Tampa, FL, US 5 HEGP, ORL, Paris, France 6 InHANSE, Head and Neck Surgery, Birmingham, UK 7 German Cancer Research Center (DKFZ), Infections and Cancer Epidemiology, Heidelberg, Germany 8 Catalan Institute of Oncology - IDIBELL, On behalf of Unit of Cancer and Infection in the Cancer Epidemiology Research Programme, Hospitalet Del Llobregat, Spain
Publications: 
IPVC, Barcelona, Spain, 23-27 March 2020
Document Types: , Oral presentation
Countries: , China, France, Germany, Italy, Japan, Portugal, Spain
Condition Year Language Analysis type
, Infectious disease, Oncology 2020 English , Burden of illness, Observational study, Retrospective Field Study
 
 
Cross-sectional survey in patients with type 1 and type 2 diabetes to understand mealtime insulin unmet needs in Japan: The MINUTES-J study
Authors: Hitoshi Ishii 1, Suzuki Shuichi 2, Paul Williams 3, Sven Demiya 4, Toshihiko Aranishi 2, Tamas Treuer 5 (rwesheorj 4)
Affiliations: 1) Department of Diabetology, Nara Medical University, Nara, Japan 2) Eli Lilly Japan, K.K., Kobe, Japan 3) RWE Patient-Centered Endpoints Center of Excellence, IQVIA, Paris, France 4) IQVIA Solutions K.K., Tokyo Japan 5) Eli Lilly and Company, Budapest, Hungary
Publications: 
Diabetes Research and Clinical Practice
Document Types: , Article
Countries: , Japan
Abstract: https://www.sciencedirect.com/science/article/pii/S0168822719314494?via%3Dihub
Condition Year Language Analysis type
, Diabetes 2020 English , Patient questionnaire
 
 
IQVIA hospital information system DATA secondary use for outcome identification to assess the validity of definitions
Authors: Masaya H 1, Kenji Hamada 1, Masafumi Okada 1, Dilinuer Ainiwaer 1, Masaaki I 1, Takeshi Akiyama 1 (rwesheorj 1)
Affiliations: 1) IQVIA Solutions Japan K.K., Tokyo, Japan
Publications: 
ISPOR Asia Pacific
Document Types: , Abstract, Conference, Presentation
Countries: , Japan
Abstract: https://www.ispor.org/heor-resources/presentations-database/presentation/asia2020-3264/104325
Condition Year Language Analysis type
, Database Validity and methodology 2020 English , De-identification / anonymisation
 
 
Descriptive study on perceptions and communication of fatigue among castration resistant prostate cancer (CRPC) patients in Japan
Authors: Taro Iguchi 1, Y Nakamura 2, Takeshi Akiyama 3, Krishant Chand 3, Eric Yu 3 (rwesheorj 3)
Affiliations: 1) Osaka City University Graduate School of Medicine Urology and Pathology 2) Bayer Yakuhin Co., Ltd. Market Access Headquarters 3) IQVIA Solutions Japan Co., Ltd. Real World Evidence Solutions
Publications: 
Japanese Urological Association 2020 Annual Meeting
Document Types: , Abstract, Conference, Presentation
Countries: , Japan
Abstract: http://www.congre.co.jp/jua2020/program/files/program_1223.pdf
Condition Year Language Analysis type
, Oncology 2020 English , Patient questionnaire, Survey research
 
 
A systematic literature review of the disease and economic burden of multidrug resistance gram negative infections (MRGN) in Japan
Authors: T Hara 1, H Ikeoka 1, Adeeb Tawseef 2, Ryo Mitsuo 2 (rwesheorj 2)
Affiliations: 1) Shionogi & Co., Ltd., Osaka, Japan 2) IQVIA Solutions Japan KK, Tokyo, Japan
Publications: 
ISPOR Asia Pacific 2020 Conference
Document Types: , Abstract
Countries: , Japan
Abstract: https://www.ispor.org/heor-resources/presentations-database/presentation/asia2020-3264/103814
Condition Year Language Analysis type
, Drug Utlization Study 2020 English , Burden of illness, Literature Review
 
 
Retrospective study for comorbidities in ACTIVE population using Japanese health insurance claims database
Authors: Seok-Won Kim 1, Ayumi Morishita 1, Takeshi Akiyama 1 (rwesheorj 1)
Affiliations: 1) Real World Evidence Solutions, IQVIA Solutions Japan K.K.
Publications: 
ISPOR Asia Pacific 2020 Conference
Document Types: , Abstract
Countries: , Japan
Abstract: https://www.ispor.org/heor-resources/presentations-database/presentation/asia2020-3264/104345
Condition Year Language Analysis type
, Database Validity and methodology 2020 English , Database Study
 
 
Cost-effectiveness and budget impact analysis of a patient visit support system for blindness reduction in Japanese patients with glaucoma
Authors: Masakazu Yamada 1, Tadashi Nakano 2, Hiroyuki Matsuda 3, Seok-Won Kim 3, Yasutaka Takagi 4 (rwesheorj 3)
Affiliations: 1) Department of Ophthalmology, Kyorin University School of Medicine, Mitaka, Japan 2) Department of Ophthalmology, The Jikei University School of Medicine, Tokyo, Japan 3) Real World Evidence Solutions, IQVIA solutions Japan, Tokyo, Japan 4) Japan Medical Affairs Group, Santen Pharmaceutical Co., Ltd, Osaka, Japan
Publications: 
Journal of Medical Economics
Document Types: , Article
Countries: , Japan
Abstract: https://www.tandfonline.com/doi/full/10.1080/13696998.2020.1804392
Condition Year Language Analysis type
, Health economics 2020 English , Budget impact, Cost effectiveness
 
 
Demographic characteristics, thromboembolism risk, and treatment patterns for patients with cold agglutinin disease in Japan
Authors: Toyomi Kamesaki 1, Jun-Ichi Nishimura 2, Hideho Wada 3, Eric Yu 4, Elisa Tsao 5, Jaime Morales 5, Yuzuru Kanakura 2 6 (rwesheorj 4)
Affiliations: 1) Division of Support in Community Medicine, Center for Community Medicine, Regional Medical Center, Center for Regional Medical Care, Jichi Medical University, 3311 - 1 Yakushiji Shimotsuke-shi, Tochigi, Japan 2) Osaka University, Osaka, Japan 3) Kawasaki Medical School, Kurashiki, Japan 4) IQVIA Solutions K.K., Tokyo, Japan 5) Sanofi, Waltham, MA, USA 6) Sumitomo Hospital, Osaka, Japan
Publications: 
International Journal of Hematology
Document Types: , Article
Countries: , Japan
Abstract: https://link.springer.com/article/10.1007%2Fs12185-020-02899-6
Condition Year Language Analysis type
, Rare Diseases 2020 English , Retrospective database analysis
 
 
Evaluation of the optimal position for vedolizumab in the Japanese treatment paradigm for ulcerative colitis using Markov modeling
Authors: Akihito Uda 1, Yuki Eto 1, Yuxin Li 2, Hiroyuki Matsuda 3, Sven Demiya 3, Tomoyuki Watanabe 1, Mihoko Ota 1, Ryuichi Iwakiri 1, Ataru Igarashi 4 5 (rwesheorj 3)
Affiliations: 1) Japan Medical Office, Takeda Pharmaceutical Co. Ltd., Tokyo, Japan 2) IQVIA Solutions UK Ltd., London, UK 3) IQVIA Solutions Japan KK, Tokyo, Japan 4) Unit of Public Health and Preventive Medicine, School of Medicine, Yokohama City University, Yokohama, Kanagawa, Japan 5) Department of Health Economics and Outcomes Research, Graduate School of Pharmaceutical Sciences, The University of Tokyo, Bunkyo, Tokyo, Japan
Publications: 
Crohn's & Colitis 360
Document Types: , Article
Countries: , Japan
Abstract: https://academic.oup.com/crohnscolitis360/article/2/2/otaa017/5809344
Condition Year Language Analysis type
, Health economics 2020 English , Budget impact, Cost effectiveness, Economic evaluation
 
 
Cardiovascular and renal effectiveness of empagliflozin in routine care in East Asia: Results from the EMPRISE East Asia study
Authors: Yutaka Seino*, Dae Jung Kim, Daisuke Yabe, Elise Chia-Hui Tan, Wook-Jin Chung, Kyoung Hwa Ha, Masaomi Nangaku, Koichi Node, Riho Klement**, Atsutaka Yasui, Wei-Yu, Sunwoo Lee, Moe H Kyaw, Anouk Deruaz-Luyet, Kimberly G Brodovicz,Wayne H-H Sheu, on behalf of the EMPRISE East Asia study group
Affiliations: * Kansai Electric Power Medical Research Institute, Kobe, Japan and Kansai Electric Power Hospital, Osaka, Japan **EPID Research an IQVIA company, Tartu, Estonia
Publications: 
Endocrinology, Diabetes and Metabolism 2020;00:e00183
Document Types: , Article
Countries: , Japan, South Korea, Taiwan
Abstract: https://onlinelibrary.wiley.com/doi/full/10.1002/edm2.183
Condition Year Language Analysis type
, Cardiovascular disease, Diabetes 2020 English , Epidemiological study, Retrospective database analysis
 
 
Investigation of factors considered by health technology assessment agencies in eight countries
Authors: Akira Yuasa 1 2, Naohiro Yonemoto 1, Sven Demiya 3, Chihiro Foellscher 3, Shunya Ikeda 2 (rwesheorj 3)
Affiliations: 1) Pfizer Japan Inc, Tokyo, Japan 2) Graduate School of Medicine, International University of Health and Welfare, 1-26, Akasaka 4-chome, Minato-ku, Tokyo, 107-8402, Japan 3) IQVIA Solutions Japan K.K., Tokyo, Japan
Publications: 
PharmacoEconomics - Open
Document Types: , Article
Countries: , Japan
Abstract: https://link.springer.com/article/10.1007%2Fs41669-020-00235-6
Condition Year Language Analysis type
, Health economics 2020 English , Economic evaluation
 
 
The Certainty Framework for Assessing Real‐World Data in Studies of Medical Product Safety and Effectiveness
Authors: Noelle M. Cocoros Peter Arlett Nancy A. Dreyer Chieko Ishiguro Solomon Iyasu Miriam Sturkenboom Wei Zhou Sengwee Toh
Affiliations: 1Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, Massachusetts, USA. 2Data Analytics and Methods Task Force, European Medicines Agency, Amsterdam, The Netherlands. 3London School of Hygiene and Tropic Medicine, London, UK. 4Center for Advanced Evidence Generation, IQVIA Real World Solutions, Cambridge, Massachusetts, USA. 5Division of Epidemiology, Office of Medical Informatics and Epidemiology, Pharmaceuticals and Medical Devices Agency, Tokyo, Japan. 6Center for Observational and Real-world Evidence, Merck & Co., Inc., Kenilworth, New Jersey, USA. 7Julius Center, Global Health, University Medical Center Utrecht, Utrecht, The Netherlands.
Publications: 
https://doi.org/10.1002/cpt.2045
Document Types: , Article
Countries: , Japan, Netherlands, USA
Abstract: https://ascpt.onlinelibrary.wiley.com/doi/10.1002/cpt.2045
Condition Year Language Analysis type
, Health status & patient reported outcomes 2020 English , direct to patient research, Real World Data, Real World Evidence
 
 
The disease burden of mucormycosis in Japan: results from a systematic literature review and retrospective database study
Authors: Rie Ueno 1, Shinichi Nishimura 1, Go Fujimoto 1, Dilinuer Ainiwaer 2 (rwesheorj 2)
Affiliations: 1) MSD KK, Tokyo, Japan 2) IQVIA Solutions Japan KK, Tokyo, Japan
Publications: 
Current Medical Research and Opinion
Document Types: , Article
Countries: , Japan
Abstract: https://www.tandfonline.com/doi/full/10.1080/03007995.2020.1846510
Condition Year Language Analysis type
, Infectious disease 2020 English , Database Study, Literature Review
 
 
Investigation of factors considered in the health technology assessment conducted by regulatory authority in eight countries
Authors: Akira Yuasa 1, Naohiro Yonemoto 1, Sven Demiya 2, Chihiro Foellscher 2, Shunya Ikeda 3 (rwesheorj 2)
Affiliations: 1) Pfizer Japan Inc., Tokyo, Japan 2) IQVIA Solutions Japan, Tokyo, Japan 3) Graduate School of Medicine, International University of Health and Welfare, Tokyo, Japan
Publications: 
ISPOR 2020 Conference
Document Types: , Abstract
Countries: , Australia, Canada, France, Germany, Italy, Japan, Spain, UK
Abstract: https://www.ispor.org/heor-resources/presentations-database/presentation/intl2020-3182/101019
Condition Year Language Analysis type
2020 English
 
 
Voice technology - an opportunity to broaden participation in patient reported outcomes research
Authors: Sven Demiya 1, C Neumann 2, Chieh Chu 1, Krishant Chand K1, Eric Yu 1 (rwesheorj 1)
Affiliations: 1) IQVIA Solutions Japan, Tokyo, Japan 2) easyDialog GK, Tokyo, Japan
Publications: 
ISPOR Asia Pacific 2020 Conference
Document Types: , Abstract
Countries: , Japan
Abstract: https://www.ispor.org/heor-resources/presentations-database/presentation/asia2020-3264/103782
Condition Year Language Analysis type
2020 English , Machine Learning/Artificial Intelligence, Survey research
 
 
Three Asian Type 2 Diabetes cardiovascular risk equations simulation using the IQVIA Core Diabetes Model
Authors: Ryo Mitsuo 1, Sven Demiya 1, Adeeb Tawseef 1, Raf De Moor 1, M Ramos, M Lamotte (rwesheorj 1)
Affiliations: IQVIA HEOR Zaventem Brussels
Publications: 
Japan Diabetes Society 2020 Annual Meeting
Document Types: , Poster
Countries: , Asia Pacific, Japan
Condition Year Language Analysis type
, Diabetes, Health economics 2020 English , Clinical setting: Primary care, Cost effectiveness
 
 
The clinical and economic burden of cytomegalovirus management post allogeneic hematopoietic stem cell transplantation in Japan - a retrospective database study
Authors: Rie Ueno 1, Shinichi Nishimura 1, Go Fujimoto 1, Yi Piao 2, Katsuto Takenaka 3 (rwesheorj A)
Affiliations: 1) MSD K.K., Tokyo, Japan 2) IQVIA Solutions Japan K.K., Tokyo, Japan 3) Department of Hematology, Clinical Immunology and Infectious Diseases, Graduate School of Medicine, Ehime University, Toon, Japan
Publications: 
Current Medical Research and Opinion
Document Types: , Article
Countries: , Japan
Abstract: https://www.tandfonline.com/doi/full/10.1080/03007995.2019.1649379
Condition Year Language Analysis type
, Hematology 2019 English , Epidemiological study, Retrospective database analysis
 
 
Medication adherence/persistence and demographics of Japanese dyslipidemia patients on statin-ezetimibe as a separate pill combination lipid-lowering therapy- an observational pharmacy claims database study
Authors: Tatsuya Umeda 1, Ai Hayashi 1, Go Fujimoto 1, Yi Piao 2, Nobutomo Matsui 2, Shigeru Tokita 1
Affiliations: 1) Medical Affairs, MSD K.K. 2) Real World Insights, IQVIA Solutions Japan K.K.
Publications: 
Circulation Journal Circ J. 2019 Jul 25;83(8):1689-1697
Document Types: , Abstract, Article, Poster
Countries: , Japan
Abstract: https://www.jstage.jst.go.jp/article/circj/83/8/83_CJ-18-1344/_article
Condition Year Language Analysis type
, Hematology 2019 English , Epidemiological study, Retrospective database analysis
 
 
Natural hisotry of oral human papillomavirus infection in healthy populations: Design of the Prevalence of Oral HPV infection, a Global assessment, THE PROGRESS STUDY
Authors: Pedros M1, Morais E2, Roset M1, Kothari S3, Alemany L5, Mirghani H6, Mehanna H7, Waterboer T8, Roberts C3, Vendetti N3, Walia A3, Drury R2, Luxembourg A3, Giuliano A9
Affiliations: 1 IQVIA, Barcelona, Spain 2 MSD, Lyon, France 3 Merck & Co, Inc., Kenilworth, NJ, US 5 Catalan Institute of Oncology, Cancer Epidemiology Research Program and IDIBELL i CIBERESP, Barcelona, Spain 6 Hôpital Européen Georges-Pompidou Université Paris-Descartes, Paris, France 7 Institute of Head & Neck Studies and Education (InHANSE), University of Birmingham, Birmingham, United kingdom 8 German Cancer Research Center (DKFZ), Heidelberg, Germany 9 Moffitt Cancer Center, Florida, US
Publications: 
EUROGIN, Monaco, France, 4-7 December 2019
Document Types: , Oral presentation
Countries: , China, France, Germany, Italy, Japan, Spain, UK, USA
Abstract: http://merck.creative.studios.s3-website-us-east-1.amazonaws.com/EUROGIN_2019/2019_EUROGIN_Pedros_NaturalHistory.pdf
Condition Year Language Analysis type
, Clinical practice, Infectious disease, Methodology 2019 English , Epidemiological study, Observational study, Population Based Study
 
 
Clinical characteristics, treatment patterns, and thromboembolic risk of patients with cold agglutinin disease (CAD) in Japan
Authors: Toyomi Kamesaki 1, Jun-ichi Nishimura 2, Hideho Wada 3, Eric Yu 4, Elisa Tsao 5, Jaime Morales 5, Yuzuru Kanakura 2 (rwesheorj 4)
Affiliations: 1) Jichi Medical University 2) Osaka University, Osaka, Japan 3) Kawasaki Medical School, Kurashiki, Japan 4) IQVIA, Tokyo, Japan 5) Sanofi, Waltham, MA, USA
Publications: 
European Hematology Association 2019 Conference
Document Types: , Abstract, Poster
Countries: , Japan
Abstract: https://library.ehaweb.org/eha/2019/24th/266231/jun-ichi.nishimura.clinical.characteristics.treatment.patterns.and.html
Condition Year Language Analysis type
, Hematology 2019 English , Epidemiological study, Retrospective database analysis
 
 
Profiling and treatment patterns in NSCLC patients with CNS (brain) metastases in Europe and Asia
Authors: Mari E1, Mpima S2, Guglielmetti F1, Nasuti P2, Manuguid F2, Heitner Enschede S3
Affiliations: 1IQVIA , Milan, Italy 2IQVIA , London, UK 3IQVIA Inc, USA
Publications: 
Document Types: 
Countries: , China, France, Germany, Italy, Japan, South Korea, Spain, UK
Abstract: http://ascopubs.org/doi/abs/10.1200/JCO.2018.36.15_suppl.e21085
Condition Year Language Analysis type
2018 English
 
 
Patterns of care and of biomolecular characterization of Right, Transverse, and Left Colorectal Cancer from real-life evidence in Asia Pacific and European countries
Authors: Ettore M1, Mpima S2, Guglielmetti F1, Nasuti P2
Affiliations: 1IQVIA , Milan, Italy 2IQVIA , London, UK
Publications: 
ESMO 2018
Document Types: , Poster
Countries: , China, France, Germany, Italy, Japan, South Korea, Spain, UK
Abstract: ESMO 2018 Congress
Condition Year Language Analysis type
, Oncology 2018 English
 
 
Patterns of Therapy in Regional Lymph Node Positive Prostate Cancer in Europe and Asia: An International Analysis
Authors:  Prentice M1, Mpima S2, Martinez de Pinillos A2, Nasuti P2, Davda R, Payne H 1
Affiliations: 1 University College Hospital, London, UK 2 IQVIA , London, UK
Publications: 
ESMO 2018
Document Types: , Poster
Countries: , China, France, Germany, Italy, Japan, South Korea, Spain, UK
Abstract: ESMO 2018 Congress
Condition Year Language Analysis type
, Oncology 2018 English
 
 
Initial Management of localised prostate cancer in the Elderly: An International Data Review
Authors: Prentice M1, Mpima S2, Martinez de Pinillos A2, Nasuti P2, Davda R1, Payne H1
Affiliations: 1 University College Hospital, London, UK 2 IQVIA , London, UK
Publications: 
SIOG 2018
Document Types: , Poster
Countries: , China, France, Germany, Italy, Japan, South Korea, Spain, UK
Condition Year Language Analysis type
, Oncology 2018 English
 
 
Profiling and treatment patterns in NSCLC patients with CNS (brain) metastases in Europe and Asia
Authors: Mari E1, Mpima S2, Guglielmetti F1, Nasuti P2, Manuguid F2, Heitner Enschede S3
Affiliations: 1IQVIA , Milan, Italy 2IQVIA , London, UK 3IQVIA Inc, USA
Publications: 
JCO ( ASCO 2018)
Document Types: , Abstract
Countries: , Asia Pacific, China, Europe, France, Germany, Italy, Japan, South Korea, Spain, UK
Abstract: http://ascopubs.org/doi/abs/10.1200/JCO.2018.36.15_suppl.e21085
Condition Year Language Analysis type
, Oncology 2018 English
 
 
Studies on economic burden of disease using real-world healthcare data in Japan: a systematic review
Authors: WY Kuan 1, Sven Demiya 1, Eric Yu 1, Y Piao 1 (rwesheorj 1)
Affiliations: 1) IQVIA Solutions Japan K.K., Tokyo, Japan
Publications: 
ISPOR Asia Pacific 2018 Conference
Document Types: , Abstract
Countries: , Japan
Abstract: https://www.ispor.org/heor-resources/presentations-database/presentation/ispor-asia-pacific-2018/studies-on-economic-burden-of-disease-using-real-world-healthcare-data-in-japan-a-systematic-review
Condition Year Language Analysis type
, Rare Diseases 2018 English , Economic evaluation, Literature Review
 
 
A comparison of patient-reported outcomes (PRO) study between Japan and the United States in oncology research: a systematic literature review
Authors: Krishant Chand 1, Junko Morii 1, T Sato 1 (rwesheorj 1)
Affiliations: 1) IQVIA Solutions Japan K.K., Tokyo, Japan
Publications: 
ISPOR Asia Pacific 2018 Conference
Document Types: , Abstract
Countries: , Japan
Abstract: https://www.ispor.org/heor-resources/presentations-database/presentation/ispor-asia-pacific-2018/a-comparison-of-patient-reported-outcomes-pro-study-between-japan-and-the-united-states-in-oncology-research-a-systematic-literature-review
Condition Year Language Analysis type
, Oncology 2018 English , Literature Review
 
 
Harmo an eletronic medicine diary designed to manage data on prescription at pharmacies on the cloud server and even more
Authors: A Igarashi 1, Sven Demiya 2, Eric Yu 2, G Fukushi 3, Y Takagi 3 (rwesheorj 2)
Affiliations: 1) University of Tokyo, Tokyo, Japan 2) IMS Japan K.K., Tokyo, Japan 3) SONY Corp., Tokyo, Japan
Publications: 
ISPOR Asia Pacific 2018 Conference
Document Types: , Abstract
Countries: , Japan
Abstract: https://www.ispor.org/heor-resources/presentations-database/presentation/ispor-asia-pacific-2018/harmo-an-eletronic-medicine-diary-designed-to-manage-data-on-prescription-at-pharmacies-on-the-cloud-server-and-even-more
Condition Year Language Analysis type
, Methodology 2018 English , direct to patient research
 
 
Clinical profile, management and resource utilisation of patients with alcohol use disorders (AUD) in Japan
Authors: Moriguchi Y 1, Tan KH 2, Morii Junko 3, Iso H 3, Roset M 4 (rwesheorj 3)
Affiliations: 1) Lundbeck Japan, K.K., Tokyo, Japan 2) Lundbeck Singapore Pte Ltd, Singapore, Singapore 3) IQVIA, Tokyo, Japan 4) IQVIA, Barcelona, Spain
Publications: 
ISPOR Asia Pacific
Document Types: , Conference, Presentation
Countries: , Japan
Abstract: https://www.ispor.org/heor-resources/presentations-database/presentation/ispor-asia-pacific-2018/clinical-profile-management-and-resource-utilisation-of-patients-with-alcohol-use-disorders-aud-in-japan
Condition Year Language Analysis type
, Mental health 2018 English , Patient questionnaire
 
 
Evaluating the cost-effectiveness results of diagnostic strategies for hepatocellular carcinoma in Japan
Authors: M Uchida-Nakakoji 1, Akihiro Nishie 2, Graeme Ball 3, Eliza Kruger 4, Bruce Crawford 3, Hiroshi Honda 2
Affiliations: 1) Bayer Yakuhin Ltd., Tokyo, Japan 2) Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan 3) QuintilesIMS, Tokyo, Japan 4) QuintilesIMS, San Francisco, CA, USA
Publications: 
ISPOR 2017 Conference
Document Types: , Abstract
Countries: , Japan
Abstract: https://www.ispor.org/heor-resources/presentations-database/presentation/ispor-22nd-annual-international-meeting/evaluating-the-cost-effectiveness-results-of-diagnostic-strategies-for-hepatocellular-carcinoma-in-japan
Condition Year Language Analysis type
, Oncology 2017 English , Cost effectiveness
 
 
Cost-effectiveness of EOB-MRI for hepatocellular carcinoma in Japan
Authors: Akihiro Nishie 1, Satoshi Goshima 2, Hiroki Haradome 3, Etsuro Hatano 4, Yasuharu Imai 5, Masatoshi Kudo 6, Masanori Matsuda 7, Utaroh Motosugi 7, Satoshi Saitoh 8, Kengo Yoshimitsu 9, Bruce Crawford 10, Eliza Kruger 10, Graeme Ball 10, Hiroshi Honda 11
Affiliations: 1) Kyushu University, Fukuoka, Japan 2) Gifu University Hospital, Gifu, Japan 3) Nihon University Hospital, Tokyo, Japan 4) Hyogo University Hospital, Hyogo, Japan 5) Ikeda Municipal Hospital, Osaka, Japan 6) Kindai University Hospital, Osaka, Japan 7) Yamanashi University, Yamanashi, Japan 8) Toranomon Hospital, Tokyo, Japan 9) Fukuoka University Hospital, Fukuoka, Japan 10) Quintiles IMS, Tokyo, Japan 11) Kyushu University, Fukuoka, Japan"
Publications: 
Clinical Therapeutics
Document Types: , Article
Countries: , Japan
Abstract: https://www.sciencedirect.com/science/article/pii/S0149291817301807?via%3Dihub
Condition Year Language Analysis type
, Oncology 2017 English , Cost analysis
 
 
Drug utilization in rheumatoid arthritis from a large japanese hospital administrative database
Authors: Crawford B, Kim J
Affiliations: IMS Health, Real-world Evidence Solutions, Tokyo, Japan
Publications: 
pharmacoepidemiology and drug safety 2015; 24: 142
Document Types: , Abstract
Countries: , Japan
Condition Year Language Analysis type
, Rheumatology 2015 English , Retrospective database analysis
 
 
Real world studies using Japanese administrative databases: Chronic hepatitis C treatment pattern and resource use
Authors: Crawford B1, Tang A, Li H, Burns L, Wada K, McDonald J
Affiliations: 1Japan & APAC, IMS Health KK, Tokyo, Japan,
Publications: 
ISPOR 17th Annual European Congress, 8-12 November 2014, Amsterdam, The Netherlands
Document Types: , Abstract
Countries: , Japan
Condition Year Language Analysis type
, Infectious disease 2014 English , Real World Evidence
 
 
Evolution of oral anticancer treatments use in France from 2004 to 2012: the Re-ACTOR Study.
Authors: Benjamin L, Maurel F, Bardoulat I, Ricarte C
Affiliations: 1 Glaxosmithkline, 2 Health Economics and Outcomes Research, Marly le Rol, France, 3 IMS Health, La Defense, France
Publications: 
ISPOR Europe 2013 Annual meeting
Document Types: , Poster
Countries: , China, France, Germany, Italy, Japan, Korea, Spain, Taiwan, UK
Abstract: http://www.valueinhealthjournal.com/article/S1098-3015(13)02489-3/fulltext
Condition Year Language Analysis type
, Oncology 2013 English , Retrospective database analysis
 
 
Current situation of oral anticancer treatments use in France: the ACTOR Study.
Authors: Benjamin L, Maurel F, Bardoulat I, Ricarte C
Affiliations: 1 Glaxosmithkline, 2 Health Economics and Outcomes Research, Marly le Rol, France, 3 IMS Health, La Defense, France
Publications: 
ISPOR Europe 2013 Annual meeting
Document Types: , Abstract
Countries: , China, France, Germany, Italy, Japan, Korea, Spain, Taiwan, UK
Abstract: http://www.valueinhealthjournal.com/article/S1098-3015(13)02492-3/fulltext
Condition Year Language Analysis type
, Oncology 2013 English
 
 
A health economic evaluation of aspirin in the primary prevention of cardiovascular disease in Japan.
Authors: Tsutani K, Igarashi A, Fujikawa K, Evers T, Kubin M, Lamotte M, Annemans L
Affiliations: 
Publications: 
Intern Med., 2007, 46(4): 157-162
Document Types: , Article
Countries: , Japan
Abstract: http://www.unboundmedicine.com/medline/ebm/record/17301509/full_citation/A_health_economic_evaluation_of_aspirin_in_the_primary_prevention_of_cardiovascular_disease_in_Japan_
Condition Year Language Analysis type
, Cardiovascular disease 2007 English , Economic evaluation
 
 
Copyright 2024 IMS Health Incorporated. All rights reserved.